- Home
- RPRX vs JLL Comparison
RPRX vs JLL Comparison
Compare RPRX & JLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | JLL |
|---|---|---|
| Founded | 1996 | 1997 |
| Country | United States | United States |
| Employees | N/A | 113200 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 15.7B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | RPRX | JLL |
|---|---|---|
| Price | $49.36 | $338.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $51.40 | ★ $365.33 |
| AVG Volume (30 Days) | ★ 2.5M | 370.3K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.89% | N/A |
| EPS Growth | N/A | ★ 45.13 |
| EPS | 1.78 | ★ 16.40 |
| Revenue | $2,378,193,000.00 | ★ $26,115,600,000.00 |
| Revenue This Year | $38.63 | $7.71 |
| Revenue Next Year | $4.73 | $6.99 |
| P/E Ratio | $27.85 | ★ $20.45 |
| Revenue Growth | 5.06 | ★ 11.45 |
| 52 Week Low | $31.97 | $211.86 |
| 52 Week High | $50.08 | $363.06 |
Technical Indicators
Market Signals| Indicator | RPRX | JLL |
|---|---|---|
| Relative Strength Index (RSI) | 60.46 | 59.92 |
| Support Level | $35.34 | $334.29 |
| Resistance Level | N/A | $359.82 |
| Average True Range (ATR) | 0.88 | 9.51 |
| MACD | 0.03 | 2.04 |
| Stochastic Oscillator | 77.82 | 63.02 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $86 billion for clients across diverse public and private real estate strategies.